Related Experiment Videos
Chronic hepatitis C in Israeli children
Efrat Broide1, Shimon Reif, Eli Brazovski
1Pediatric Gastroenterology Unit, Institute of Gastroenterology, Assaf Harofeh Medical Center, Zerifin 70300, Israel. efibroide@yahoo.com
Fetal and Pediatric Pathology
|August 13, 2005
Summary
Pediatric chronic hepatitis C (CHC) shows distinct liver histopathology, with inflammation and sinusoidal lymphocytosis common. Most children exhibit minimal or no fibrosis, suggesting a slower disease progression in pediatric CHC.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Viral Hepatitis Research
Background:
- Chronic hepatitis C (CHC) in adults is well-characterized.
- Histopathological data for CHC in children remain limited and debated.
- Understanding pediatric CHC liver disease is crucial for appropriate management.
Purpose of the Study:
- To investigate the histopathological features of CHC in pediatric patients in Israel.
- To compare pediatric CHC liver histology with established adult findings.
- To assess the progression of liver fibrosis in children with CHC.
Main Methods:
- Retrospective review of 20 liver biopsy specimens from children diagnosed with CHC.
- Evaluation of key histopathological parameters: inflammation, fibrosis, necrosis, steatosis, cholestasis, bile duct damage, sinusoidal lymphocytosis, and glycogen storage.
- Correlation analysis between age at biopsy and histological findings.
Main Results:
- The most frequent findings were portal inflammation (95%) and lobular inflammation (70%).
- Sinusoidal lymphocytosis was observed in 85% of cases, and glycogen storage vacuoles in 40%.
- The majority of children (80%) showed no fibrosis; 15% had mild and 5% moderate fibrosis. Advanced fibrosis or cirrhosis was absent.
Conclusions:
- Pediatric CHC presents a unique histopathological phenotype compared to adults.
- The natural history of CHC in children appears to be slowly progressive, regardless of disease duration.
- These findings highlight the need for specific considerations in managing pediatric chronic hepatitis C.